Hello Cake is a technology company.
Hello Cake specializes in sexual health medication and specialty lubricants, aiming to redefine sexual healthcare accessibility through innovation and personalized care.
Hello Cake has raised $13.0M across 3 funding rounds.
Hello Cake has raised $13.0M in total across 3 funding rounds.
Hello Cake has raised $13.0M in total across 3 funding rounds.
Hello Cake's investors include Lerer Hippeau, Alumni Ventures, Brand Foundry Ventures, Curie.Bio, Operator Partners, Primary Venture Partners, Toba Capital, Jonathan Neman, Yumin Choi, Imaginary Ventures, Pace Capital.
Hello Cake is a sexual health and wellness brand offering products like lubricants, sex toys, supplements, over-the-counter medications, and telehealth-prescribed treatments for erectile dysfunction (ED) and female sexual dysfunction (FSD).[1][2][3][5] It serves adult consumers seeking to enhance sexual experiences, solving issues like low libido, performance anxiety, and arousal challenges through accessible, discreet DTC and retail channels.[1][2][5] The company has shown strong growth, raising over $36M in funding—including an $18M Series B in 2024—acquiring Wet's parent Trigg Laboratories for vertical integration, and expanding to 13,000+ retail doors at Walmart, Target, CVS, and Walgreens.[2][3]
Founded in 2018 in North Hollywood, California (later headquartered in Calabasas), Hello Cake emerged from Wipe Holdings, initially focusing on sexual wellness wipes before expanding into a broader portfolio.[1][3] Co-founder Mitch Okris has driven its evolution, launching DTC in 2020 with rapid traction—hitting $1M+ revenue in under a year—and pivoting to telehealth in 2023 with dissolvable ED meds, followed by women's libido treatments like Libido Lift Rx.[2][3] Key milestones include Walmart entry in 2021, Target/CVS in 2022, retail doubling from 2023-2024, and the Trigg acquisition to build manufacturing capabilities.[2]
Hello Cake rides the booming sexual wellness trend, blending e-commerce, telehealth, and consumer products in a market shifting toward stigma-free, tech-enabled intimacy solutions.[1][2] Timing aligns with post-pandemic demand for DTC health personalization and retail normalization of sex products, fueled by competitors' acquisitions (e.g., Dame buying Emojibator/Chakrubs).[1] Market forces like HIPAA-compliant telehealth and vertical integration position it to challenge incumbents, while influencing the ecosystem by mainstreaming prescription sexual health via major retailers and online platforms.[2][5]
Hello Cake's prescription telehealth and retail dominance signal a trajectory toward category leadership, with vertical integration accelerating product launches and margins.[2] Trends like AI-driven personalization in wellness and expanding FSD/ED awareness will shape growth, potentially evolving its influence through more acquisitions or international retail pushes. As a vertically integrated player in a consolidating space, it ties back to its core mission: making premium sexual health as routine as any wellness buy.
Hello Cake has raised $13.0M across 3 funding rounds. Most recently, it raised $8.0M Series A in September 2022.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Sep 1, 2022 | $8.0M Series A | Lerer Hippeau | |
| Jun 1, 2021 | $4.0M Seed | Alumni Ventures, Brand Foundry Ventures, Curie.Bio, Lerer Hippeau, Operator Partners, Primary Venture Partners, Toba Capital, Jonathan Neman, Yumin Choi | |
| Jun 1, 2020 | $1.0M Seed | Alumni Ventures, Brand Foundry Ventures, Curie.Bio, Imaginary Ventures, Operator Partners, Pace Capital, Primary Venture Partners, Toba Capital, Jonathan Neman, Yumin Choi |